The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Anti-Peptic Ulcer Drugs Market Research Report 2024

Global Anti-Peptic Ulcer Drugs Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1408659

No of Pages : 81

Synopsis
Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
The global Anti-Peptic Ulcer Drugs market was valued at US$ 8713 million in 2023 and is anticipated to reach US$ 21220 million by 2030, witnessing a CAGR of 13.4% during the forecast period 2024-2030.
Global Anti-Peptic Ulcer Drugs key players include AstraZeneca, Ask-pharm, Takeda, Yangtze River Pharm, Shandong Luoxin, etc. Global top five players hold a share about 50%.
In terms of product, the segment includes Proton Pump Inhibitors (PPIs), Potassium-Competitive Acid Blockers (P-CAB), Antacids, H2 Antagonists, Ulcer Protective Drugs. And in terms of application, the application includes Gastritis, Gastric Ulcers, Duodenal Ulcers, Gastroesophageal Reflux Disease (GERD).
This report aims to provide a comprehensive presentation of the global market for Anti-Peptic Ulcer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Peptic Ulcer Drugs.
Report Scope
The Anti-Peptic Ulcer Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Peptic Ulcer Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Peptic Ulcer Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Ask-pharm
Takeda
Yangtze River Pharm
Shandong Luoxin
Huadong Medicine
Changzhou Siyao
Beijing Yuekang
Guangdong Dahua
Xian Janssen
Segment by Type
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Ulcer Protective Drugs
Segment by Application
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-Peptic Ulcer Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Peptic Ulcer Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Proton Pump Inhibitors (PPIs)
1.2.3 Potassium-Competitive Acid Blockers (P-CAB)
1.2.4 Antacids
1.2.5 H2 Antagonists
1.2.6 Ulcer Protective Drugs
1.3 Market by Application
1.3.1 Global Anti-Peptic Ulcer Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Gastritis
1.3.3 Gastric Ulcers
1.3.4 Duodenal Ulcers
1.3.5 Gastroesophageal Reflux Disease (GERD)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-Peptic Ulcer Drugs Market Perspective (2019-2030)
2.2 Anti-Peptic Ulcer Drugs Growth Trends by Region
2.2.1 Global Anti-Peptic Ulcer Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Anti-Peptic Ulcer Drugs Historic Market Size by Region (2019-2024)
2.2.3 Anti-Peptic Ulcer Drugs Forecasted Market Size by Region (2025-2030)
2.3 Anti-Peptic Ulcer Drugs Market Dynamics
2.3.1 Anti-Peptic Ulcer Drugs Industry Trends
2.3.2 Anti-Peptic Ulcer Drugs Market Drivers
2.3.3 Anti-Peptic Ulcer Drugs Market Challenges
2.3.4 Anti-Peptic Ulcer Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-Peptic Ulcer Drugs Players by Revenue
3.1.1 Global Top Anti-Peptic Ulcer Drugs Players by Revenue (2019-2024)
3.1.2 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Anti-Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-Peptic Ulcer Drugs Revenue
3.4 Global Anti-Peptic Ulcer Drugs Market Concentration Ratio
3.4.1 Global Anti-Peptic Ulcer Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Peptic Ulcer Drugs Revenue in 2023
3.5 Anti-Peptic Ulcer Drugs Key Players Head office and Area Served
3.6 Key Players Anti-Peptic Ulcer Drugs Product Solution and Service
3.7 Date of Enter into Anti-Peptic Ulcer Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Peptic Ulcer Drugs Breakdown Data by Type
4.1 Global Anti-Peptic Ulcer Drugs Historic Market Size by Type (2019-2024)
4.2 Global Anti-Peptic Ulcer Drugs Forecasted Market Size by Type (2025-2030)
5 Anti-Peptic Ulcer Drugs Breakdown Data by Application
5.1 Global Anti-Peptic Ulcer Drugs Historic Market Size by Application (2019-2024)
5.2 Global Anti-Peptic Ulcer Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Anti-Peptic Ulcer Drugs Market Size (2019-2030)
6.2 North America Anti-Peptic Ulcer Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Anti-Peptic Ulcer Drugs Market Size by Country (2019-2024)
6.4 North America Anti-Peptic Ulcer Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-Peptic Ulcer Drugs Market Size (2019-2030)
7.2 Europe Anti-Peptic Ulcer Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Anti-Peptic Ulcer Drugs Market Size by Country (2019-2024)
7.4 Europe Anti-Peptic Ulcer Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-Peptic Ulcer Drugs Market Size (2019-2030)
8.2 Asia-Pacific Anti-Peptic Ulcer Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Anti-Peptic Ulcer Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Anti-Peptic Ulcer Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-Peptic Ulcer Drugs Market Size (2019-2030)
9.2 Latin America Anti-Peptic Ulcer Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Anti-Peptic Ulcer Drugs Market Size by Country (2019-2024)
9.4 Latin America Anti-Peptic Ulcer Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-Peptic Ulcer Drugs Market Size (2019-2030)
10.2 Middle East & Africa Anti-Peptic Ulcer Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Introduction
11.1.4 AstraZeneca Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024)
11.1.5 AstraZeneca Recent Development
11.2 Ask-pharm
11.2.1 Ask-pharm Company Detail
11.2.2 Ask-pharm Business Overview
11.2.3 Ask-pharm Anti-Peptic Ulcer Drugs Introduction
11.2.4 Ask-pharm Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024)
11.2.5 Ask-pharm Recent Development
11.3 Takeda
11.3.1 Takeda Company Detail
11.3.2 Takeda Business Overview
11.3.3 Takeda Anti-Peptic Ulcer Drugs Introduction
11.3.4 Takeda Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024)
11.3.5 Takeda Recent Development
11.4 Yangtze River Pharm
11.4.1 Yangtze River Pharm Company Detail
11.4.2 Yangtze River Pharm Business Overview
11.4.3 Yangtze River Pharm Anti-Peptic Ulcer Drugs Introduction
11.4.4 Yangtze River Pharm Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024)
11.4.5 Yangtze River Pharm Recent Development
11.5 Shandong Luoxin
11.5.1 Shandong Luoxin Company Detail
11.5.2 Shandong Luoxin Business Overview
11.5.3 Shandong Luoxin Anti-Peptic Ulcer Drugs Introduction
11.5.4 Shandong Luoxin Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024)
11.5.5 Shandong Luoxin Recent Development
11.6 Huadong Medicine
11.6.1 Huadong Medicine Company Detail
11.6.2 Huadong Medicine Business Overview
11.6.3 Huadong Medicine Anti-Peptic Ulcer Drugs Introduction
11.6.4 Huadong Medicine Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024)
11.6.5 Huadong Medicine Recent Development
11.7 Changzhou Siyao
11.7.1 Changzhou Siyao Company Detail
11.7.2 Changzhou Siyao Business Overview
11.7.3 Changzhou Siyao Anti-Peptic Ulcer Drugs Introduction
11.7.4 Changzhou Siyao Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024)
11.7.5 Changzhou Siyao Recent Development
11.8 Beijing Yuekang
11.8.1 Beijing Yuekang Company Detail
11.8.2 Beijing Yuekang Business Overview
11.8.3 Beijing Yuekang Anti-Peptic Ulcer Drugs Introduction
11.8.4 Beijing Yuekang Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024)
11.8.5 Beijing Yuekang Recent Development
11.9 Guangdong Dahua
11.9.1 Guangdong Dahua Company Detail
11.9.2 Guangdong Dahua Business Overview
11.9.3 Guangdong Dahua Anti-Peptic Ulcer Drugs Introduction
11.9.4 Guangdong Dahua Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024)
11.9.5 Guangdong Dahua Recent Development
11.10 Xian Janssen
11.10.1 Xian Janssen Company Detail
11.10.2 Xian Janssen Business Overview
11.10.3 Xian Janssen Anti-Peptic Ulcer Drugs Introduction
11.10.4 Xian Janssen Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024)
11.10.5 Xian Janssen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’